GSK plc

GSKNYSEHealthcare● Active

$51.52

+$0.25(+0.49%)

Market Cap$103.6B

P/E Ratio—

52W High$61.7

52W Low$35.45

Avg Volume4.2M

Open$51.42

Beta0.29

Free Cash Flow Financials Revenue

GSK plc (GSK) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

GSK · free cash flow · updated Jun 8, 2026

Core FCF metrics

GSK · FCF · TTM · margin & CAGR

Free cash flow was $5.82B for FY2025 (fiscal year ending 2025-12-31), up 63.1% year-over-year The FCF margin was 17.8%. Five-year CAGR stands at -2.2%.

FY2025 Free Cash Flow$5.82B▲ +63.1% YoY

Trailing 12M (TTM)$6.24Btrailing 4 quarters sum

FCF Margin17.8%$5.82B ÷ revenue

3-Year CAGR-4.8%FY2022 → FY2025

5-Year CAGR-2.2%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

GSK · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$7.14B(1.32B)$5.82B▲ +63.1%17.8%

FY2024$6.55B(2.98B)$3.57B▼ 42.9%11.4%

FY2023$7.89B(1.63B)$6.26B▼ 7.3%20.6%

FY2022$8.16B(1.41B)$6.75B▲ +27.5%23.0%

FY2021$7.95B(2.65B)$5.30B▼ 18.4%21.4%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

GSK · P/FCF · FCF yield · FCF per share

GSK plc (GSK) trades at a FCF yield of 6.50% and a price-to-free-cash-flow ratio of 8.4x. FCF per share stands at $6.16, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

6.50%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$6.16

TTM FCF ÷ Shares Outstanding

Price / FCF

x8.4

Share Price ÷ FCF per Share

EV / FCF (TTM)

x18.5

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

GSK · cash flow statement · operating / investing / financing

For FY2025, GSK plc generated $7.14B in operating cash flow and spent 1.32B in capital expenditures, yielding $5.82B in free cash flow.

Operating Activities

+$7.14B

Cash from core business operations

2025-12-31

Investing Activities

−$5.72B

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$1.59B

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($7.14B) − |CapEx| (1.32B) = FCF ($5.82B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

GSK vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

GSK plcYOU

GSK

$5.82B+63.1%17.8%

30%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

GSK plc (GSK) reported free cash flow of $5.82B for FY2025 (fiscal year ending 2025-12-31), up 63.1% year-over-year. The FCF margin was 17.8%.

Based on available data, GSK plc has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $6.75B in FY2022. The 5-year CAGR stands at -2.2%.

GSK plc's FCF yield is 6.50% and price-to-FCF ratio is 8.4x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

GSK free cash flow · 8 questions

GSK plc free cash flow was $5.82B for FY2025, up 63.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $6.24B.

GSK free cash flowGSK FCFGSK FCF 2025GSK free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · GSK plc · GSK plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026